NEW YORK--(BUSINESS WIRE)--Bristol-Myers
Squibb Company (NYSE: BMY) today announced that Ann Powell Judge
will join the company as senior vice president, Human Resources, in
March. She will report to Lamberto
Andreotti, chief executive officer, and will be a member of the
company’s Senior Management Team.

“Ann brings more than 20 years of broad international human resources
experience across multiple industries that will be important to my
management team and to our company as we continue to execute our
BioPharma strategy,” said Lamberto Andreotti, chief executive officer,
Bristol-Myers Squibb. “Her leadership abilities and practical business
focus will help ensure we have the right human resource development and
organizational effectiveness strategy as we continue to build a strong
foundation for future growth.”

Prior to joining Bristol-Myers Squibb, Ms. Judge was chief human
resources officer at Shire Pharmaceuticals. Before Shire, Ms. Judge was
corporate vice president, Human Resources, for the Pharmaceutical
Division at Wyeth. During her tenure at Wyeth, Ms. Judge also held
positions of responsibility for human resources in the commercial
organization and in the global manufacturing unit. Previously, she spent
13 years at The Dow Chemical Company, where she worked internationally
in a variety of human resources positions of increasing scope and
responsibility, spending some time living and working in Germany and
Switzerland.

“I am looking forward to joining the team at Bristol-Myers Squibb,” said
Ms. Judge. “The company is well-known for its focused and successful
BioPharma strategy, and its understanding that people development and
organizational effectiveness is a key component of that success.”

Ms. Judge has a bachelor’s degree in Psychology from the University of
Iowa and a master’s degree in Industrial Relations from the University
of Minnesota.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information, please
visit www.bms.com
or follow us on Twitter at http://twitter.com/bmsnews.